Skip to main content
Premium Trial:

Request an Annual Quote

Qvella Raises $20M in Series A Financing

NEW YORK (GenomeWeb) – Canadian molecular diagnostics firm Qvella announced today it has raised $20 million in Series A financing.

The funding round was co-led by RA Capital Management and Whitecap Venture Partners, and included Hatteras Venture Partners and Sands Capital Ventures as syndicate partners.

"This latest round of funding provides us with the capital to support our ongoing research and development, and build out our team," Tino Alavie, president, CEO, and co-founder of Toronto-based Qvella, said in a statement.

The core technology of Qvella, called Field Activated Sample Treatment, uses electrical lysing and direct-from-blood sample detection in a spatially multiplexed array, according to the company's website. The firm is developing the technology for rapid pathogen detection.

"Solutions that enable patients to receive the right treatment quickly will fulfill a key unmet need in microbiology," Parker Cassidy, Qvella board member and executive in residence at RA Capital Management, said in today's statement. "Qvella has the perfect combination of technology, team, and potential to impact how antibiotics are delivered and developed."

The Scan

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.

Clinical Trial Participants, Investigators Point to Importance of Clinical Trial Results Reporting in Canadian Study

Public reporting on clinical trial results is crucial, according to interviews with clinical trial participants, investigators, and organizers from three provinces appearing in BMJ Open.

Old Order Amish Analysis Highlights Autozygosity, Potential Ties to Blood Measures

Researchers in BMC Genomics see larger and more frequent runs-of-homozygosity in Old Order Amish participants, though only regional autozygosity coincided with two blood-based measures.

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.